Leverkusen, Germany

Ahmed Hegasy


Average Co-Inventor Count = 1.7

ph-index = 7

Forward Citations = 149(Granted Patents)


Company Filing History:


Years Active: 1985-1997

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Ahmed Hegasy: Innovator in Pharmaceutical Preparations

Introduction

Ahmed Hegasy is a notable inventor based in Leverkusen, Germany. He has made significant contributions to the field of pharmaceuticals, holding a total of 9 patents. His work focuses on innovative formulations that enhance the efficacy of various medications.

Latest Patents

Among his latest patents, one invention relates to pharmaceutical preparations containing a specific crystal modification of isopropyl-(2-methoxyethyl) 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate, commonly known as nimodipine. This invention details a process for preparing this specific crystal modification, referred to as 'modification II'. Another significant patent involves solid medicament formulations containing nifedipine. This invention provides solid pharmaceutical compositions that include nifedipine crystals with a specific surface area of 1.0 to 4.0 m²/g, mixed with a solid diluent. These compositions aim to overcome the deficiencies found in prior art formulations of nifedipine, which is recognized for its effectiveness as a coronary vasodilator.

Career Highlights

Ahmed Hegasy is currently associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical industry. His work at Bayer has allowed him to focus on developing innovative solutions that address critical health issues.

Collaborations

Throughout his career, Ahmed has collaborated with esteemed colleagues such as Klaus-Dieter Ramsch and Manfred Winter. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Ahmed Hegasy's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through effective medication formulations. His patents reflect a deep understanding of pharmaceutical science and a dedication to enhancing patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…